C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 1/21 (2006.01) A61K 39/00 (2006.01) A61K 39/04 (2006.01) C07K 14/195 (2006.01) C07K 14/35 (2006.01) C07K 19/00 (2006.01) C12N 15/00 (2006.01) C12P 21/02 (2006.01)
Patent
CA 2523084
The present invention relates to novel recombinant vaccines providing protective immunity against tuberculosis. Further, the present invention refers to novel recombinant nucleic acid molecules, vectors containing said nucleic acid molecules, cells transformed with said nucleic acid molecules and polypeptides encoded by said nucleic acid molecules.
La présente invention a trait à de nouveaux vaccins recombinants assurant une immunité protectrice contre la tuberculose. L'invention a également trait à des molécules d'acide nucléique recombinantes, des vecteurs contenant lesdites molécules d'acide nucléique, des cellules transformées avec lesdites molécules d'acide nucléique et des polypeptides codés par lesdites molécules d'acide nucléique.
Grode Leander
Hess Jurgen
Kaufmann Stefan H. E.
Raupach Barbel
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.v.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Tuberculosis vaccine with improved efficacy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tuberculosis vaccine with improved efficacy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tuberculosis vaccine with improved efficacy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2051405